Diagnos Laboratorium Utama Tbk. vs Wahana Pronatural Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Wahana Pronatural Tbk. trades at Rp117 (market cap 143.95B, 286.2K 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 2.2× Wahana Pronatural Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 286.2K). Which is the better fit depends on your goals.
| DGNS | WAPO | |
|---|---|---|
Market Cap | 310.75B | 143.95B |
Volume | 963.6K | 286.2K |
Lot | 9.64K | 2.86K |
Turnover | 217.67M | 33.23M |
Average Price | 225.89 | 116.12 |
Value | 217.67M | 33.23M |
Indicative Equilibrium Price | 226 | 117 |
Indicative Equilibrium Volume | 1K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Wahana Phonix Mandiri (the Company) Tbk was established on August 7, 1993 under the name PT Golden Phoenix. On January 31, 2000 the Company changed its named to be PT Wahana Phonix Mandiri, Tbk. Deed by making statements shareholders meeting extraordinary No.2 on June 2, 2012 by Wachid Hasyim, notary in Surabaya, the Company name was changed to PT Wahana Pronatural Tbk
Read more on WAPO →